Tandem Diabetes (TNDM) Gains From Innovation Amid Competition [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
However, ongoing macroeconomic challenges pose concerns for Tandem Diabetes. The stock carries a Zacks Rank #3 (Hold). In the near and long term, Tandem Diabetes aims to strategically expand the adoption of the insulin pump by people with type 1 diabetes across all its markets and produce evolved products and services to attract type 2 diabetes people who use insulin-intensive therapy. The launch of the t:slim X2 with the new continuous glucose monitor (CGM) integration has garnered a favorable response from the diabetes community for having a choice in their therapy management. In the Type 1 market, the company sees great opportunity as more than one million people in the United States are currently devoid of the benefits of insulin pump therapy and an even larger population in international markets. Moreover, the company's research indicates that more than two million people with type 2 diabetes in the United States are already insulin-dependent and do not use a pump. In 2024, t
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was upgraded by analysts at Leerink Partnrs from a "market perform" rating to an "outperform" rating.MarketBeat
- Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $45.00 price target on the stock, up previously from $34.00.MarketBeat
- TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Stifel Nicolaus from $37.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
TNDM
Earnings
- 2/21/24 - Miss
TNDM
Sec Filings
- 4/9/24 - Form ARS
- 4/9/24 - Form DEFA14A
- 4/9/24 - Form DEF
- TNDM's page on the SEC website